Clinical Trials Directory

Trials / Unknown

UnknownNCT03096236

Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Subepithelial gastric tumors are rare and usually detected incidentally. Most subepithelial tumors (SET) are benign but up to 13% of all lesions can be malignant. Histology after needle biopsy often brings no clear diagnosis in SET, so further strategy often remains unclear. Surveillance endoscopy can be associated with the risk of progression. Endoscopic resection usually is difficult, associated with high risk of complications and sometimes is not feasible. Surgical resection is also associated with a risk of complications and often refused by the patients. With the developement of the gFTRD-System gastric SET can now be resected endoscopically. The advantage of this technique is the complete resection and a full-thickness resections specimen for are definite histology.

Conditions

Interventions

TypeNameDescription
DEVICEEFTREFTR with the FTRD developed for gastric resection (gFTRD).

Timeline

Start date
2017-03-01
Primary completion
2019-03-01
Completion
2019-09-01
First posted
2017-03-30
Last updated
2017-09-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03096236. Inclusion in this directory is not an endorsement.